Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Regulus Therapeutics
(NQ:
RGLS
)
1.680
+0.030 (+1.82%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 30, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Regulus Therapeutics
< Previous
1
2
3
4
5
Next >
RGLS Stock Earnings: Regulus Therapeutics Misses EPS for Q2 2024
August 09, 2024
RGLS stock results show that Regulus Therapeutics missed analyst estimates for earnings per share the second quarter of 2024.
Via
InvestorPlace
Ball To Rally More Than 23%? Here Are 10 Top Analyst Forecasts For Tuesday
June 25, 2024
Via
Benzinga
What's Going On With Regulus Therapeutics Stock Monday?
June 24, 2024
Regulus Therapeutics announced positive results from its study related to the treatment of autosomal dominant polycystic kidney disease (AKPD).
Via
Benzinga
RGLS Stock Earnings: Regulus Therapeutics Misses EPS for Q1 2024
May 09, 2024
RGLS stock results show that Regulus Therapeutics missed analyst estimates for earnings per share the first quarter of 2024.
Via
InvestorPlace
The $5 Phenoms: 3 Cheap Stocks That Could Skyrocket by 2028
May 07, 2024
Finding good investing possibilities in the constantly changing stock market might be likened to unearthing buried jewels.
Via
InvestorPlace
12 Health Care Stocks Moving In Monday's After-Market Session
May 06, 2024
Via
Benzinga
Analyst Expectations for Regulus Therapeutics's Future
September 21, 2023
Via
Benzinga
Expert Ratings for Regulus Therapeutics
June 28, 2023
Via
Benzinga
RGLS Stock Earnings: Regulus Therapeutics Misses EPS for Q4 2023
March 21, 2024
RGLS stock results show that Regulus Therapeutics missed analyst estimates for earnings per share the fourth quarter of 2023.
Via
InvestorPlace
Why Limbach Holdings Shares Are Trading Lower By Around 15%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
March 14, 2024
Shares of Limbach Holdings, Inc. (NASDAQ: LMB) fell sharply during Thursday’s session after the company reported fourth-quarter financial results and issued FY24 revenue guidance below estimates.
Via
Benzinga
Emerging Companies: Key Developments and Investment Insights RGLS, INBS, VTAK, DYAI, TCBP
March 13, 2024
Via
AB Newswire
Gold Down Over 1%; ClearOne Shares Spike Higher
March 12, 2024
U.S. stocks traded higher toward the end of trading, with the S&P 500 index gaining over 1% on Tuesday. The Dow traded up 0.74% to 39,057.10 while the NASDAQ rose 1.41% to 16,245.83. The S&P 500 also...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Why Asana Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
March 12, 2024
Shares of Asana, Inc. (NYSE: ASAN) fell sharply during Tuesday’s session following soft FY25 revenue guidance.
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
March 12, 2024
Via
Benzinga
Nasdaq Surges Over 1%; Blade Air Mobility Shares Plummet
March 12, 2024
U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining around 1% on Tuesday. The Dow traded up 0.48% to 38,955.84 while the NASDAQ rose 1.12% to 16,198.58. The S&P 500 also...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Regulus Therapeutics Inc. (NASDAQ: RGLS) is One of Tuesday Morning’s Most Active Stocks
March 12, 2024
Via
Investor Brand Network
Dow Gains 100 Points; US Inflation Rate Rises To 3.2% In February
March 12, 2024
U.S. stocks traded higher this morning, with the Nasdaq Composite gaining around 100 points on Tuesday. Following the market opening Tuesday, the Dow traded up 0.27% to 38,873.55 while the NASDAQ rose...
Via
Benzinga
Topics
Economy
Stocks
Exposures
Interest Rates
US Equities
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
March 12, 2024
Via
Benzinga
Why Is Kidney Disease-Focused Regulus Therapeutics Stock Trading Higher On Tuesday?
March 12, 2024
Regulus Therapeutics reports findings for RGLS8429 in ADPKD study—mechanistic dose response, encouraging biomarkers, and an oversubscribed $100M equity placement at $1.60 per share.
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
March 12, 2024
Pre-market stock movers are worth checking out this morning as we get into all of the biggest winners and losers for Tuesday!
Via
InvestorPlace
12 Health Care Stocks Moving In Thursday's After-Market Session
September 21, 2023
Via
Benzinga
Regulus Therapeutics Releases Early Data From Of Investigational For Rare Type Of Kidney Disease
September 20, 2023
Regulus Therapeutics Inc (NASDAQ: RGLS) released topline results from the first cohort of patients in its Phase 1b Multiple-Ascending Dose (MAD) trial of RGLS8429 for Autosomal Dominant Polycystic
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
September 20, 2023
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
June 21, 2023
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
April 17, 2023
Via
Benzinga
Why Marpai Shares Are Trading Lower By 26%; Here Are 20 Stocks Moving Premarket
April 17, 2023
Gainers CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) jumped 153% to $5.96 in pre-market trading after jumping 243% on Friday.
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
April 17, 2023
We're starting the week with a breakdown of the biggest pre-market stock movers traders need to know about on Monday morning!
Via
InvestorPlace
12 Health Care Stocks Moving In Thursday's Intraday Session
April 13, 2023
Via
Benzinga
Why ViewRay Shares Are Trading Lower By 32%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
April 13, 2023
Gainers CXApp Inc. (NASDAQ: CXAI) jumped 105% to $3.28 after climbing over 20% on Wednesday.
Via
Benzinga
Why Regulus Therapeutics Shares Are Trading Higher Today
April 13, 2023
Regulus Therapeutics (NASDAQ: RGLS) shares are trading higher on Thursday after the company announced a $15 million private placement of equity.
Via
Benzinga
< Previous
1
2
3
4
5
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.